ArticleNature communications2026
Leveraging long read RNA-seq to decipher neuronal regulation of alternative polyadenylation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alternative polyadenylation (APA) is a pervasive co/post-transcriptional process affecting >70% of human genes which greatly enhances transcriptome diversity. Here we introduce APALORD (Alternative Polyadenylation Analysis of LOng-ReaDs), a computational framework for APA analysis of long-read (LR) RNA-seq data. For gene level APA analysis, we developed a novel method by comparing distributions of cleavage sites (CSs) between conditions. Applying APALORD to direct RNA-seq (DRS) data from human embryonic stem cells (hESCs) and derived neurons, we identified annotated and novel PASs with high positional accuracy. The transcriptome-wide APA lengthening in neurons was associated with increased usage of stronger PASs enriched for the canonical AAUAAA polyA signal, upstream UGUA and downstream GU/U-rich motifs. PAS strength was negatively correlated with the number of PASs per gene and positively correlated with gene expression levels. Application to Drosophila embryo samples led to a substantial expansion of PAS annotations and uncovered conserved features of APA regulation. A novel, low-abundance class of transcripts that do not map directly to identified PAS was identified in both species and found to display APA regulation trends. Together, APALORD offers a robust framework for high-resolution APA analysis using LR RNA-seq data across species and biological contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.